ReviewBioImpacts : BI2025
A comprehensive review on the cellular mechanism of traditional Chinese medicine in the treatment of pediatric lung diseases.
Review in BioImpacts : BI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Numerous researchers have examined the environmental and regional characteristics, as well as the mother's dwelling air quality during pregnancy, that influence children's lung disease. The most common type of medicine is Western medicine, however Chinese medicine is more effective at treating lung conditions in youngsters. The common cold, pneumonia, bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and lung cancer are among the respiratory ailments that traditional Chinese medicine (TCM) is frequently used to treat. TCM has qualities like resolving a variety of issues, focusing on several areas, and reducing harmful side effects. TCM has justified its anti-asthma, bronchiolitis, and pulmonary fibrosis (PF) effect in clinical practice but its underlying mechanism and specific role in mentioned disease are still unknown. According to some animal research, the traditional recipe, precise measurements, and organic substances extracted from TCM could considerably reduce changes in the structure of the airways and show anti-inflammatory properties. By examining these results and information, we will talk about the potential Patho mechanism that underlies asthmatic airway inflammation and remodeling as well as the special function of TCM in asthma treatment by controlling various signaling pathways. We provide a summary of the developments in research on TCM extracts for the treatment of asthma, bronchiolitis, PF, and lung cancer in this review paper. Additionally, we shall discuss a few cellular aspects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.